Invention Grant
US09562026B2 Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
有权
神经活性取代的环戊烯[a]蒽作为GABA A型受体的调节剂
![Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors](/docs/US/2017-02-07/US09562026B2/abs.jpg.600x600.jpg)
- Patent Title: Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
- Patent Title (中): 神经活性取代的环戊烯[a]蒽作为GABA A型受体的调节剂
-
Application No.: US14203678Application Date: 2014-03-11
-
Publication No.: US09562026B2Publication Date: 2017-02-07
- Inventor: Douglas Covey
- Applicant: Washington University
- Applicant Address: US MO St. Louis
- Assignee: WASHINGTON UNIVERSITY
- Current Assignee: WASHINGTON UNIVERSITY
- Current Assignee Address: US MO St. Louis
- Agency: Armstrong Teasdale LLP
- Main IPC: C07C61/125
- IPC: C07C61/125 ; C07C255/47 ; C07D303/14 ; C07C49/513
![Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors](/abs-image/US/2017/02/07/US09562026B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure is generally directed to neuroactive substituted cyclopent[a]anthracenes as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds.
Public/Granted literature
- US20140275241A1 NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS Public/Granted day:2014-09-18
Information query
